SciELO - Scientific Electronic Library Online

 
vol.18 número1Factores sociales de riesgo para la falta de cumplimiento terapéutico en pacientes con tuberculosis en PontevedraCoste-efectividad de drotrecogina alfa (activada) en el tratamiento de la sepsis grave en España índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Gaceta Sanitaria

versión impresa ISSN 0213-9111

Resumen

GONZALEZ DE ALEDO, Álvaro  y  VILORIA, Luis. Meningococcus B serosubtypes causing invasive disease in Cantabria [Spain] and agreement with the Cuban vaccine strain. Gac Sanit [online]. 2004, vol.18, n.1, pp.45-49. ISSN 0213-9111.

Objective: To determine the serosubtypes of meningococcus B causing invasive disease in Cantabria and the percentage of agreement with the Cuban vaccine strain, VA-MENGOC-BC. Methods: We performed a retrospective review of all cases of invasive disease due to meningococcus B declared through the Diseases of Mandatory Reporting System between 1st January 1998 and 28th February 2003. The bacteriological isolates of the «Marqués de Valdecilla» University Hospital, and the serosubtyping performed in the Majadahonda reference laboratory (Madrid, Spain) were also analyzed. Results: Of the 117 declared cases, serosubtype was identified in 79 (67.5%). The agreement with the Cuban vaccine strain was 67%, 71% and 76% in the age groups of newborn to 19 years, 18 months to 19 years, and 4 to 19 years, respectively. When strains with cross-protection were included, these percentages increased to 83%, 83% and 84%, respectively, in the same age groups. Conclusions: The percentage of agreement between the Cuban vaccine strain and heterologous strains with cross-protection was high. Therefore, this vaccine could be useful in Cantabria.

Palabras clave : Meningococcal vaccines; Meningococcal infections.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons